Last edition
News about "ADC Drug Substance "
Shilpa Biologicals Commissions ADC Drug Substance GMP Facility in India
Shilpa Biologicals has launched an integrated Antibody Drug Conjugate (ADC) drug substance GMP facility in India, expanding Shilpa Medicare’s 25+ years of expertise in highly potent compound manufacturing.
ADC Drug Substance | 26/06/2026 | By News Bureau
The partnership aims to speed up market entry for biopharma firms by combining Mycenax's biologics expertise with Spera Pharma’s high-potent fill-finish capabilities, offering an integrated, cost-effective ADC development platform.
ADC Drug Substance | 15/09/2025 | By Dineshwori | 296
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy